T0	Participants 79 118	patients with type 2 diabetes mellitus.
T1	Participants 231 261	patients with type 2 diabetes.
T2	Participants 355 419	patients with type 2 diabetes with suboptimal metabolic control.
T3	Participants 420 488	Patients with a baseline haemoglobin A(1c) (HbA(1c)) of 7.3 to 11.0%
T4	Participants 1817 1846	patients with type 2 diabetes